PHIO PHARMACEUTICALS CORP. Interest Paid, Including Capitalized Interest, Operating and Investing Activities
PHIO PHARMACEUTICALS CORP. (PHIO) reported Interest Paid, Including Capitalized Interest, Operating and Investing Activities of $3.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-27.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:InterestPaid · last filed 2019-03-27
- PHIO PHARMACEUTICALS CORP. interest paid, including capitalized interest, operating and investing activities for the quarter ending 2012-12-31 was $1.00K.
- PHIO PHARMACEUTICALS CORP. interest paid, including capitalized interest, operating and investing activities for the quarter ending 2012-09-30 was $29.00K.
- PHIO PHARMACEUTICALS CORP. interest paid, including capitalized interest, operating and investing activities for the quarter ending 2012-06-30 was $0.00.
- PHIO PHARMACEUTICALS CORP. interest paid, including capitalized interest, operating and investing activities for fiscal 2018 was $3.00K.
- PHIO PHARMACEUTICALS CORP. interest paid, including capitalized interest, operating and investing activities for fiscal 2017 was $0.00.
- PHIO PHARMACEUTICALS CORP. interest paid, including capitalized interest, operating and investing activities for fiscal 2012 was $30.00K.
| Period end | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 3 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 6 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 9 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 12 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 111 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 114 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 117 month |
|---|---|---|---|---|---|---|---|
| 2018-12-31 | $3.00K 10-K · filed 2019-03-27 | ||||||
| 2017-12-31 | $0.00 10-K · filed 2019-03-27 | ||||||
| 2012-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $30.00K derived: sum of 2 quarters · filed 2014-03-28 | $30.00K derived: sum of 3 quarters · filed 2014-03-28 | $30.00K 10-K · filed 2014-03-28 | |||
| 2012-09-30 | $29.00K derived: 10-Q 117 month − 10-Q 114 month · filed 2012-11-13 | $29.00K derived: sum of 2 quarters · filed 2012-11-13 | $29.00K 10-Q · filed 2013-11-14 | $37.00K 10-Q · filed 2012-11-13 | |||
| 2012-06-30 | $0.00 derived: 10-Q 114 month − 10-Q 111 month · filed 2012-08-14 | $8.00K 10-Q · filed 2012-08-14 | |||||
| 2012-03-31 | $8.00K 10-Q · filed 2012-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |